Table 2.
6–24 months at transplant | 2–6 yr at transplant | 2–20 yr at transplant | ||||||
---|---|---|---|---|---|---|---|---|
|
|
|
||||||
OR (95% CI) | p** | OR (95% CI) | p | OR (95% CI) | p | |||
1 yr after transplant (n = 3059) | ||||||||
| ||||||||
Underweight at transplant | 0.44 (0.28–0.71) | 0.001 | Underweight at transplant | 0.06 (0.01–0.42) | 0.005 | Underweight at transplant | 0.17 (0.05–0.55) | 0.003 |
Overweight/obese at tx | 2.41 (1.64–3.53) | <0.001 | Overweight at transplant | 2.30 (1.39–3.81) | 0.001 | Overweight at transplant | 5.98 (4.20–8.51) | <0.001 |
Obese at transplant | 3.82 (2.40–6.08) | <0.001 | Obese at transplant | 15.7 (9.35–26.3) | <0.001 | |||
Hispanic | 1.41 (0.97–2.03) | 0.07 | Hispanic | 1.60 (0.99–0.58) | 0.054 | Hispanic | 1.74 (1.18–2.55) | 0.005 |
Metabolic liver disease | 0.51 (0.32–0.81) | 0.005 | ||||||
| ||||||||
2 yr after transplant (n = 2411) | ||||||||
| ||||||||
Underweight at transplant | 0.53 (0.37–0.77) | 0.001 | Underweight at transplant | 0.29 (0.10–0.83) | 0.021 | |||
Overweight/obese at tx | 2.09 (1.37–3.19) | 0.001 | Overweight at transplant | 4.08 (2.28–7.32) | <0.001 | Overweight at transplant | 3.38 (2.25–5.08) | <0.001 |
Obese at transplant | 4.82 (2.81–8.27) | <0.001 | Obese at transplant | 10.1 (5.62–18.0) | <0.001 | |||
Hispanic | 1.34 (0.93–1.94) | 0.117 | Hispanic | 1.54 (0.87–2.76) | 0.141 | |||
Female | 1.23 (0.93–1.64) | 0.154 | Female | 0.63 (0.40–0.99) | 0.043 | |||
Biliary atresia | 1.81 (0.94–3.48) | 0.075 | Biliary atresia | 2.06 (1.00–4.21) | 0.049 | |||
Cholestatic liver disease | 2.02 (0.94–4.37) | 0.073 | ||||||
Other diagnoses | 2.17 (0.91–5.15) | 0.079 | ||||||
| ||||||||
5 yr after transplant (n = 1308) | ||||||||
| ||||||||
Underweight at transplant | 0.44 (0.24–0.81) | 0.008 | ||||||
Overweight/obese at tx | 3.28 (1.83–5.87) | <0.001 | Obese at transplant | 2.19 (1.09–4.41) | 0.028 | Overweight at transplant | 2.49 (1.29–4.82) | 0.007 |
African American | 1.78 (1.07–2.97) | 0.027 | Hispanic | 2.25 (1.10–4.61) | 0.026 | Obese at transplant | 5.55 (2.23–13.8) | <0.001 |
Other ethnicity | 8.58 (1.66–44.3) | 0.01 | Other ethnicity | 6.30 (0.90–44.2) | 0.064 | Other ethnicity | 6.84 (1.26–37.2) | 0.026 |
Biliary atresia | 0.35 (0.15–0.83) | 0.016 | ||||||
Cholestatic liver disease | 0.20 (0.06–0.71) | 0.016 | ||||||
| ||||||||
10 yr after transplant (n = 442) | ||||||||
| ||||||||
6–24 months at transplant | 2–20 yr at transplant | |||||||
Overweight at transplant | 2.20 (0.81–5.95) | 0.122 | ||||||
Female | 2.30 (1.05–5.02) | 0.036 | ||||||
Hispanic | 2.29 (0.94–5.63) | 0.069 | Asian | 5.83 (0.77–44.4) | 0.089 |
All OR adjusted for age (yr) within age category, gender, race/ethnicity, primary diagnosis (indication for transplant), and weight status at transplant. OR compare groups listed to referent groups: male, Caucasian, diagnosis of acute liver failure, normal weight at transplant.
p-values considered significant if p < 0.05, retained in table for comparison if p < 0.15.